Details for New Drug Application (NDA): 206687
✉ Email this page to a colleague
NDA 206687 describes SODIUM ACETATE, which is a drug marketed by Fresenius Kabi Usa, Hikma, Hospira, and Milla Pharms, and is included in four NDAs. It is available from five suppliers. Additional details are available on the SODIUM ACETATE profile page.
The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.
The generic ingredient in SODIUM ACETATE is sodium acetate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium acetate profile page.
Summary for 206687
| Tradename: | SODIUM ACETATE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | sodium acetate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 206687
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SODIUM ACETATE | sodium acetate | SOLUTION;INTRAVENOUS | 206687 | ANDA | Fresenius Kabi USA, LLC | 63323-032 | 63323-032-00 | 20 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (63323-032-00) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE (63323-032-04) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 400MEQ/100ML (4MEQ/ML) | ||||
| Approval Date: | Oct 30, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
